Genous Bio-engineered R stent update

OrbusNeich completed enrollment of a Chinese trial in 180 patients evaluating its Genous Bio-engineered R stent vs. the Endeavor Sprint stent from Medtronic Inc. (NYSE:MDT, Minneapolis, Minn.). Genou...